Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change

Journal of Neuroscience

Volumn 35, Issue 1, 2015, Pages 267-286

  Anticevic, Alan ^a,b,c,d   Hu, Xinyu ^a   Xiao, Yuan ^a   Hu, Junmei ^a   Li, Fei ^a   Bi, Feng ^a   Cole, Michael W ^e   Savic, Aleksandar ^f   Yang, Genevieve J ^b,d   Repovs, Grega ^g   Murray, John D ^h   Wang, Xiao Jing ^h   Huang, Xiaoqi ^a   Lui, Su ^a   Krystal, John H ^b   Gong, Qiyong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Abraham Ribicoff Research Facilities   (United States)

^d YALE UNIVERSITY   (United States)

^e RUTGERS UNIVERSITY   (United States)

^f University of Zagreb   (Croatia)

^g UNIVERSITY OF LJUBLJANA   (Slovenia)

^h NEW YORK UNIVERSITY   (United States)

Author keywords

Computational modeling; First episode; Hyperconnectivity; Longitudinal; Prefrontal cortex; Schizophrenia

Indexed keywords

GLUTAMIC ACID;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; FUNCTIONAL CONNECTIVITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; HUMAN EXPERIMENT; HYPERCONNECTIVITY; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROPHYSIOLOGY; PREFRONTAL CONNECTIVITY; PREFRONTAL CORTEX; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; STATISTICAL ANALYSIS; ADOLESCENT; EARLY DIAGNOSIS; FOLLOW UP; LONGITUDINAL STUDY; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; NERVE NET; PREFRONTAL CORTEX; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84920512226     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2310-14.2015     Document Type: Article

References (100)

1. Andreasen NC, Pressler M, Nopoulos P, Miller D, Ho BC (2010) Antipsy-chotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry 67:255–262.
2. Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH (2012a) The role of default network deactivation in cognition and disease. Trends Cogn Sci 16:584–592.
3. Anticevic A, Brumbaugh MS, Winkler AM, Lombardo LE, Barrett J, Corlett PR, Kober H, Gruber J, Repovs G, Cole MW, Krystal JH, Pearlson GD, Glahn DC (2013) Global prefrontal and fronto-amygdala dysconnectiv-ity in bipolar I disorder with psychosis history. Biol Psychiatry 73:565-573.
4. Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith M, Wang XJ, Krystal JH, Corlett PR (2012b) NMDA receptor function in large-scale anti-correlated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci USA 109:16720–16725.
5. Anticevic A, Repovs G, Barch DM (2013a) Working memory encoding and maintenance deficits in schizophrenia: neural evidence for activation and deactivation abnormalities. Schizophr Bull 39:168–178.
6. Anticevic A, Cole MW, Repovs G, Murray JD, Brumbaugh MS, Winkler AM, Savic A, Krystal JH, Pearlson GD, Glahn DC (2014a) Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness. Cereb Cortex 24:3116–3130.
7. Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MB, Li CS, Pittenger C (2014b) Global resting-state fMRI analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry 75:595–605.
8. Anticevic A, Corlett PR, Cole MW, Savic A, Gancsos M, Tang Y, Repovs G, Murray JD, Driesen NR, Morgan PT, Ke X, Krystal JH (2014c) NMDA receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biol Psychiatry. In press.
9. Barch DM, Ceaser A (2012) Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci 16:27–34.
10. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kotter R, Li SJ, Lin CP, Lowe MJ, Mackay C, Madden DJ, Madsen KH, Margulies DS, May-berg HS, McMahon K, Monk CS, Mostofsky SH, Nagel BJ, Pekar JJ, Peltier SJ, Petersen SE, Riedl V, Rombouts SA, Rypma B, Schlaggar BL, Schmidt S, Seidler RD, Siegle GJ, Sorg C, Teng GJ, Veijola J, Villringer A, Walter M, Wang L, Weng XC, Whitfield-Gabrieli S, Williamson P, Win-dischberger C, Zang YF, Zhang HY, Castellanos FX, Milham MP (2010) Toward discovery science of human brain function. Proc Natl Acad Sci USA 107:4734–4739.
11. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefron-tal cortex in healthy volunteers. Am J Psychiatry 154:805–811.
12. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, Munafo MR (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365–376.
13. Cannon TD, Thompson PM, van Erp TG, Toga AW, Poutanen VP, Huttunen M, Lonnqvist J, Standerskjold-Nordenstam CG, Narr KL, Khaledy M, Zoumalan CI, Dail R, Kaprio J (2002) Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci USA 99:3228-3233.
14. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65:28–37.
15. Carter CS, Perlstein W, Ganguli R, Brar J, Mintun M, Cohen JD (1998) Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry 155:1285–1287.
16. Chan RC, Di X, McAlonan GM, Gong QY (2011) Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizo-phr Bull 37:177–188.
17. Chang C-C, Lin C-J (2011) LIBSVM: A library for support vector machines. ACM Transactions on Intelligent Systems and Technology 2: 1:27.
18. Cho RY, Konecky RO, Carter CS (2006) Impairments in frontal cortical gamma synchrony and cognitive controlinschizophrenia. Proc Natl Acad Sci USA 103:19878–19883.
19. Cobia DJ, Smith MJ, Wang L, Csernansky JG (2012) Longitudinal progres-sionof frontal and temporallobechangesin schizophrenia. Schizophr Res 139:1–6.
20. Cohen J (1992) A power primer. Psychol Bull 112:155–159.
21. Cole MW, Pathak S, Schneider W (2010) Identifying the brain’s most globally connected regions. Neuroimage 49:3132–3148.
22. Cole MW, Anticevic A, Repovs G, Barch D (2011a) Variable global dyscon-nectivity and individual differences in schizophrenia. Biol Psychiatry 70: 43–50.
23. Cole MW, Etzel JA, Zacks JM, Schneider W, Braver TS (2011b) Rapid transfer of abstract rules to novel contexts in human lateral prefrontal cortex. Front Hum Neurosci 5:142.
24. Cole MW, Yarkoni T, Repovs G, Anticevic A, Braver TS (2012) Global connectivity of prefrontal cortex predicts cognitive control and intelligence. J Neurosci 32:8988–8999.
25. de Castro-Manglano P, Mechelli A, Soutullo C, Gimenez-Amaya J, Ortuno F, McGuire P (2011) Longitudinal changesinbrain structure following the first episode of psychosis. Psychiatry Res 191:166–173.
26. Deco G, Jirsa VK (2012) Ongoing cortical activity at rest: criticality, multi-stability, and ghost attractors. J Neurosci 32:3366–3375.
27. Deco G, Ponce-Alvarez A, Mantini D, Romani GL, Hagmann P, Corbetta M (2013) Resting-state functional connectivity emerges from structurally and dynamically shaped slow linear fluctuations. J Neurosci 33:11239-11252.
28. Dragovic M, Hammond G (2007) A classification of handedness using the Annett Hand Preference Questionnaire. Br J Psychol 98:375–387.
29. Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun V, D’Souza DC, Gueorguieva R, He G, Ramachandran R, Suckow RF, Anticevic A, Morgan PT, Krystal JH (2013a) Relationship of resting brain hyperconnec-tivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry 18:1199–1204.
30. Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D’Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH (2013b) The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology 38:2613–2622.
31. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E (2008) The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165:1015–1023.
32. Fair DA, Cohen AL, Dosenbach NU, Church JA, Miezin FM, Barch DM, Raichle ME, Petersen SE, Schlaggar BL (2008) The maturing architecture of the brain’s default network. Proc Natl Acad Sci USA 105:4028-4032.
33. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355.
34. Fitzsimmons J, Kubicki M, Shenton ME (2013) Review of functional and anatomical brain connectivity findings in schizophrenia. Curr Opin Psychiatry 26:172–187.
35. Fornito A, Yoon J, Zalesky A, Bullmore ET, Carter CS (2011) General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry 70:64–72.
36. Fornito A, Zalesky A, Pantelis C, Bullmore ET (2012) Schizophrenia, neu-roimaging and connectomics. Neuroimage 62:2296–2314.
37. Fox MD, Greicius M (2010) Clinical applications of resting state functional connectivity. Front Syst Neurosci 4:19.
38. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME (2005) The human brain is intrinsically organized into dynamic, anticor-related functional networks. Proc Natl Acad Sci USA 102:9673–9678.
39. Friston KJ (2011) Functional and effective connectivity: a review. Brain Connectivity 1:13–36.
40. Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J, Lonnqvist J, Cannon TD (2003) Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 53:624–626.
41. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI (2005) Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25:60–69.
42. Goldman-Rakic PS (1991) Prefrontal cortical dysfunction inschizophrenia: the relevance of working memory. In: Psychopathology and the brain (Carroll BJ, Barrett JE, eds), pp 1–23. New York: Raven.
43. Gonzalez-Burgos G, Lewis DA (2012) NMDA receptor hypofunction, parvalbumin-positive neurons and cortical gamma oscillations in schizophrenia. Schizophr Bull 38:950–957.
44. Gotts SJ, Saad ZS, Hang JJ, Wallace GL, Cox RW, Martin A (2013) The perils of global signal regression for group comparisons: a case study of autism spectrum disorders. Front Hum Neurosci 7.
45. Haber SN (2003) The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 26:317–330.
46. Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC (2014) Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology 39:1020–1030.
47. Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, Sporns O (2008) Mapping the structural core of human cerebral cortex. PLoS Biol 6:e159.
48. Holt DJ, Lakshmanan B, Freudenreich O, Goff DC, Rauch SL, Kuperberg GR (2011) Dysfunction of a cortical midline network during emotional appraisals in schizophrenia. Schizophr Bull 37:164–176.
49. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496–11500.
50. Honey G, Bullmore E (2004) Human pharmacological MRI. Trends Pharmacol Sci 25:366–374.
51. Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III–the final common pathway. Schizophr Bull 35:549–562.
52. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S (2012) The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Arch Gen Psychiatry.
53. Insel TR (2010) Rethinking schizophrenia. Nature 468:187–193.
54. Javitt DC (2009) Sensory processing in schizophrenia: neither simple nor intact. Schizophr Bull 35:1059–1064.
55. Karlsgodt KH, Sun D, Jimenez AM, Lutkenhoff ES, Willhite R, van Erp TG, Cannon TD (2008) Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 20:1297-1327.
56. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276.
57. Krystal JH, D’Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psy-chopharmacology (Berl) 169:215–233.
58. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neurore-port 6:869–872.
59. Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr (2001) Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 158:1797–1808.
60. Lewis DA, Curley AA, Glausier JR, Volk DW (2012) Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neuro-sci 35:57–67.
61. Lui S, Li T, Deng W, Jiang L, Wu Q, Tang H, Yue Q, Huang X, Chan RC, Collier DA, Meda SA, Pearlson G, Mechelli A, Sweeney JA, Gong Q (2010) Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by “resting state” functional magnetic resonance imaging. Arch Gen Psychiatry 67:783-792.
62. Marek GJ, Behl B, Bespalov AY, Gross G, Lee Y, Schoemaker H (2010) Glu-tamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain? Mol Pharmacol 77:317–326.
63. Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull 39:120–129.
64. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A (2001) Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 58: 148–157.
65. McCarley RW, Salisbury DF, Hirayasu Y, Yurgelun-Todd DA, Tohen M, Zarate C, Kikinis R, Jolesz FA, Shenton ME (2002) Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry 59:321–331.
66. Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349–1352.
67. Murray CJL, Lopez AD, Harvard School of Public Health, World Health Organization., World Bank (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and riskfactors in 1990 and projected to 2020. Cambridge, MA: Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank; Distributed by Harvard UP.
68. Natsubori T, Inoue H, Abe O, Takano Y, Iwashiro N, Aoki Y, Koike S, Yahata N, Katsura M, Gonoi W, Sasaki H, Takao H, Kasai K, Yamasue H (2014) Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia. Schizophr Bull 40: 1128–1139.
69. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15:1–25.
70. Norman KA, Polyn SM, Detre GJ, Haxby JV (2006) Beyond mind-reading: multi-voxel pattern analysis of fMRI data. Trends Cogn Sci 10:424–430.
71. Palaniyappan L, Simmonite M, White TP, Liddle EB, Liddle PF (2013) Neural primacy of the salience processing system in schizophrenia. Neuron 79:814–828.
72. Pinault D (2008) N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry 63:730–735.
73. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE (2012) Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 59:2142–2154.
74. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE (2013) Steps toward optimizing motion artifact removal in functional connectivity MRI; a reply to Carp. Neuroimage 76:439–441.
75. Reichenberg A, Harvey PD, Bowie CR, Mojtabai R, Rabinowitz J, Heaton RK, Bromet E (2009) Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophr Bull 35:1022-1029.
76. Repovs G, Barch DM (2012) Working memory related brain network connectivity in individuals with schizophrenia and their siblings. Front Hum Neurosci 6.
77. Repovs G, Csernansky JG, Barch DM (2011) Brain network connectivity in individuals with schizophrenia and their siblings. Biol Psychiatry 69:967-973.
78. Rolls ET, Deco G (2010) A computational neuroscience approach to schizophrenia and its onset. Neurosci Biobehav Rev.
79. Saad ZS, Gotts SJ, Murphy K, Chen G, Jo HJ, Martin A, Cox RW (2012) Trouble at rest: how correlation patterns and group differences become distorted after global signal regression. Brain Connectivity 2:25–32.
80. Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I, Inbar BP, Corcoran CM, Lieberman JA, Moore H, Small SA (2013) Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 78:81–93.
81. Scholvinck ML, Maier A, Ye FQ, Duyn JH, Leopold DA (2010) Neural basis of global resting-state fMRI activity. Proc Natl Acad Sci US A107:10238-10243.
82. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 36:1342–1356.
83. Smith SM, Nichols TE (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83–98.
84. Stone JM, Day F, Tsagaraki H, Valli I, McLean MA, Lythgoe DJ, O’Gorman RL, Barker GJ, McGuire PK; OASIS (2009) Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry 66:533–539.
85. Sun L, Castellanos N, Grutzner C, Koethe D, Rivolta D, Wibral M, Kranaster L, Singer W, Leweke MF, Uhlhaas PJ (2013) Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia. Schizophr Res 150:519-525.
86. Theberge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK, Northcott S, Menon RS, Neufeld RW, Rajakumar N, Pavlosky W, Dens-more M, Schaefer B, Williamson PC (2007) Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry 191:325–334.
87. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL (2001) Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 98:11650–11655.
88. Uhlhaas PJ (2013) Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia. Curr Opin Neurobiol 23:283–290.
89. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100–113.
90. Van Snellenberg JX, Torres IJ, Thornton AE (2006) Functional neuroimag-ing of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 20:497–510.
91. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Mis-simer J, Angst J (1997) Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7:9–24.
92. Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL (2000) Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34:35–43.
93. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study. Lancet 380:2163–2196.
94. Wang XJ (2002) Probabilistic decision making byslow reverberation incor-tical circuits. Neuron 36:955–968.
95. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669.
96. Whitfield-Gabrieli S, Ford JM (2012) Default mode network activity and connectivity in psychopathology. Annu Rev Clin Psychol 8:49–76.
97. Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, Shenton ME, Green AI, Nieto-Castanon A, LaViolette P, Wo-jcik J, Gabrieli JD, Seidman LJ (2009) Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci USA 106:1279-1284.
98. Wong KF, Wang XJ (2006) A recurrent network mechanism of time integration in perceptual decisions. J Neurosci 26:1314-1328.
99. Woodward ND, Karbasforoushan H, Heckers S (2012) Thalamocortical dysconnectivity in schizophrenia. Am J Psychiatry 169:1092–1099.
100. Yang GJ, Murray JD, Repovs G, Cole MW, Savic A, Glasser MF, Pittenger C, Krystal JH, Wang XJ, Pearlson GD, Glahn DC, Anticevic A (2014) Altered global brain signal in schizophrenia. Proc Natl Acad Sci USA 111: 7438–7443.